Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats
View Patent ↗The present invention relates to compositions and methods for expressing mini-dystrophin peptides. In particular, the present invention provides compositions comprising nucleic acid sequences that are shorter than wild-type dystrophin cDNA and that express mini-dystrophin peptides that function in a similar manner as wild-type dystrophin proteins. The present invention also provides compositions comprising mini-dystrophin peptides, and methods for expressing mini-dystrophin peptides in target cells.
1. A composition comprising an isolated nucleic acid encoding a mini-utrophin peptide, wherein said mini-utrophin peptide comprises:
a) a spectrin-like repeat domain comprising 4 human utrophin spectrin-like repeats, wherein said mini-utrophin peptide contains no more than 4 human utrophin spectrin-like repeats, wherein each of said 4 human utrophin spectrin-like repeats is selected from one of the twenty-two utrophin spectrin-like repeats in the human utrophin protein which is encoded by SEQ ID NO:3; and
b) an actin binding domain.
2. The composition of claim 1 , wherein said nucleic acid sequence further comprises an expression vector that comprises a promoter sequence, and wherein said nucleic acid sequence is operably linked to said promoter sequence.
3. The composition of claim 1 , wherein said spectrin-like repeat encoding sequences are precise spectrin-like repeat encoding sequences.
4. A composition comprising an isolated nucleic acid encoding a mini-utrophin peptide, wherein said mini-utrophin peptide comprises:
a) a spectrin-like repeat domain comprising 4 human utrophin spectrin-like repeats, wherein said mini-utrophin peptide contains no more than 4 human utrophin spectrin-like repeats, wherein each of said 4 human utrophin spectrin-like repeats is selected from one of the twenty-two utrophin spectrin-like repeats in the human utrophin protein which is encoded by SEQ ID NO:3; and
b) at least one hinge region.
5. The composition of claim 4 , wherein said nucleic acid sequence further comprises an expression vector that comprises a promoter sequence, and wherein said nucleic acid sequence is operably linked to said promoter sequence.
6. The composition of claim 4 , wherein said spectrin-like repeat encoding sequences are precise spectrin-like repeat encoding sequences.
7. The composition of claim 4 , further comprising c) an actin-binding domain.